Reducing Cardiovascular Events in Your Patients with Type 2 Diabetes Mellitus

Reducing Cardiovascular Events in Your Patients with Type 2 Diabetes Mellitus
LEARNING OBJECTIVES
After reading this article, the clinician
should be able to:
1. Describe why glycemic control alone is
insufficient to prevent long-term adverse
cardiovascular outcomes
2. Characterize the cardiovascular complications
observed in type 2 diabetes
mellitus
3. Describe the results of cardiovascular
outcome trials of glucose-lowering medications
for type 2 diabetes mellitus, focusing
on medications shown to reduce
cardiovascular events
4. Individualize glucose-lowering medication
shown to reduce cardiovascular
events in patients with type 2 diabetes
mellitus and with or without established
atherosclerotic cardiovascular disease,
heart failure, or chronic kidney disease
TARGET AUDIENCE
Family physicians and clinicians who wish
to gain increased knowledge and greater
competency regarding primary care management
of diabetes mellitus.

PHYSICIANS: To receive CME credit,
please read the journal article and, on completion,
go to www.pceconsortium.org/
CVEvents to complete the online post-test
and receive your certificate of credit.
PHYSICIAN ASSISTANTS: AAPA accepts
certificates of participation of educational
activities certified for AMA PRA Category
1 Credit™ from organizations accredited
by ACCME or a recognized state medical
society.
NURSE PRACTITIONERS AND REGISTERED
NURSES: The American Nurses
Credentialing Center accepts AMA PRA
Category 1 Credit™ issued by organizations
accredited by the ACCME (Accreditation
Council for Continuing Medical Education)
for recertification.